A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

Conditions:   Inflammatory Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of BreastInterventions:   Drug: Eribulin;   Drug: Adriamycin;   Drug: CyclophosphamideSponsors:   Dana-Farber Cancer Institute;   Eisai Inc.Not yet recruiting - verified December 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials